Investing.com -- Wolfe Research reshuffled its U.S. retail coverage on Monday, upgrading Target to Outperform and selecting it as a top pick into year-end, while downgrading Home Depot and Five Below to Peer Perform.
News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
Home Depot and Lowe’s both offer similar appeal, but valuation, yield, and dividend-growth history make this matchup closer than it looks.
With an annual dividend yield of 2.97%, The Home Depot, Inc. (NYSE:HD) is included among the 12 Best Dividend Stocks to Invest in According to Hedge Funds. The Home Depot, Inc. (NYSE:HD) is the largest home improvement specialty retailer in the world, engaging in the sale of building materials and home improvement products. The company operates over […]
Three Wall Street firms hit Home Depot (NYSE:HD) with price target cuts on the same day following the home improvement giant’s Q1 FY2026 results, signaling a coordinated valuation reset across the sell side. Piper Sandler trimmed its target to $378 from $421, RBC Capital lowered to $340 from $377, and Wells Fargo cut to $360 ... Home Depot Price Targets Slashed Across Wall Street After Q1: Has the Home Improvement Slowdown Just Begun?
Home Depot (HD) on Tuesday reported fiscal first-quarter results above market expectations despite c
Investing.com -- Analysts at Citigroup upgraded Lowe's to “Buy” in a new earnings preview report, arguing the home improvement retailer is well-positioned to outperform rivals despite ongoing macroeconomic uncertainty and a sluggish housing market.
Bank of America reinstated coverage of Home Depot (NYSE:HD) stock with a Buy rating and a $374 price target on May 5, naming the home improvement giant its preferred stock in the sector. The firm expects Home Depot’s comparable sales growth to outperform the company’s peers, driven by higher Pro customer penetration and traffic trends ... BofA Just Named Home Depot the Top Pick in Home Improvement: Price Target Set at $374